Two DZL early-career researchers from the BREATH site have been selected for the National Translational Tandem Program for Gene- and Cell-Based Therapies (nTTP-GCT). Their interdisciplinary team, combining basic research and clinical expertise, aims to develop...
Researchers at the DZL site in Munich have discovered a promising new approach to treating pulmonary fibrosis and recently published their findings in Nature Communications. The study explores innovative strategies for treating pulmonary fibrosis.
After a lung transplant, preventive treatment with specific antibodies can reduce the risk of infection with SARS-CoV-2. Scientists at the DZL sites in Munich and Hanover discovered this.
An international research team, led by lung researchers from Giessen, has discovered a new repair mechanism with therapeutic potential. The work has now been published in "Nature Communications."
DZL researchers at Helmholtz Munich and their collaborators developed the Human Lung Cell Atlas using artificial intelligence (AI)-based techniques. This atlas elucidates the diversity of single lung cell types and allows learning about lung biology...
Lung transplantation is an established therapy option for children and young people with serious and progressive lung diseases without any other alternative treatment.
The DZL Annual Report 2020 has been published in German and English and is now available from the Media Center.
The only curative therapy for final lung disease is allogeneic lung transplantation (LuTx), which is reserved for a small group of needy individuals due to the increasing disparity between the number of patients on the...
Every year, DZL allocates part of its budget to innovative clinical trials that are based on initiatives by DZL scientists (Investigator Initiated Trials). Four more trials, which will be described more specifically hereinafter, will be...
An international team led by DZL researcher Dr. Danny Jonigk has been able to prove changes in the lung tissue caused by SARS-CoV-2. The findings of the study show a funda-mental difference to lung damage...
DZL PI Prof. Dr. Axel Haverich was honored with the renowned Fritz Behrens Prize for his life’s work on June 17th in Hannover.
DZL Researchers at Hannover Medical School (MHH) have performed the first living donor lung transplant in Germany.
